Here, we showed that miR-200 inhibited CAF activation by targeting NRP2/VEGFR signaling, decreasing the aggressiveness of lung cancer cells, preventing M2 polarization of macrophages, and suppressing the angiogenic sprouting of vascular endothelial cells. The gene discussed is NRP2; the disease is lung carcinoma.